These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 19379723

  • 1. ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-alpha level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice.
    Kadoshima-Yamaoka K, Goto M, Murakawa M, Yoshioka R, Tanaka Y, Inoue H, Murafuji H, Kanki S, Hayashi Y, Nagahira K, Ogata A, Nakatsuka T, Fukuda Y.
    Eur J Pharmacol; 2009 Jun 24; 613(1-3):163-6. PubMed ID: 19379723
    [Abstract] [Full Text] [Related]

  • 2. Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo.
    Goto M, Kadoshima-Yamaoka K, Murakawa M, Yoshioka R, Tanaka Y, Inoue H, Murafuji H, Kanki S, Hayashi Y, Nagahira K, Ogata A, Nakatsuka T, Fukuda Y.
    Eur J Pharmacol; 2010 May 10; 633(1-3):93-7. PubMed ID: 20132810
    [Abstract] [Full Text] [Related]

  • 3. Phosphodiesterase 7A inhibitor ASB16165 suppresses proliferation and cytokine production of NKT cells.
    Goto M, Murakawa M, Kadoshima-Yamaoka K, Tanaka Y, Inoue H, Murafuji H, Hayashi Y, Miura K, Nakatsuka T, Nagahira K, Chamoto K, Fukuda Y, Nishimura T.
    Cell Immunol; 2009 May 10; 258(2):147-51. PubMed ID: 19477436
    [Abstract] [Full Text] [Related]

  • 4. Involvement of tumor necrosis factor (TNF)-alpha in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin edema in mice.
    Murakawa M, Yamaoka K, Tanaka Y, Fukuda Y.
    Biochem Pharmacol; 2006 Apr 28; 71(9):1331-6. PubMed ID: 16487490
    [Abstract] [Full Text] [Related]

  • 5. ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-gamma production by mouse activated T lymphocytes.
    Kadoshima-Yamaoka K, Murakawa M, Goto M, Tanaka Y, Inoue H, Murafuji H, Nagahira A, Hayashi Y, Nagahira K, Miura K, Nakatsuka T, Chamoto K, Fukuda Y, Nishimura T.
    Immunol Lett; 2009 Feb 21; 122(2):193-7. PubMed ID: 19195485
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte.
    Kadoshima-Yamaoka K, Murakawa M, Goto M, Tanaka Y, Inoue H, Murafuji H, Hayashi Y, Nagahira K, Miura K, Nakatsuka T, Chamoto K, Fukuda Y, Nishimura T.
    Int Immunopharmacol; 2009 Jan 21; 9(1):97-102. PubMed ID: 18992850
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Caffeic acid reduces cutaneous tumor necrosis factor alpha (TNF-α), IL-6 and IL-1β levels and ameliorates skin edema in acute and chronic model of cutaneous inflammation in mice.
    Zhang M, Zhou J, Wang L, Li B, Guo J, Guan X, Han Q, Zhang H.
    Biol Pharm Bull; 2014 Jan 21; 37(3):347-54. PubMed ID: 24583856
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of atopic dermatitis-like skin lesions by topical application of a novel ceramide derivative, K6PC-9p, in NC/Nga mice.
    Kang JS, Yoon WK, Youm JK, Jeong SK, Park BD, Han MH, Lee H, Moon EY, Han SB, Lee CW, Lee K, Park SK, Yang KH, Kim HM.
    Exp Dermatol; 2008 Nov 21; 17(11):958-64. PubMed ID: 18721197
    [Abstract] [Full Text] [Related]

  • 13. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.
    Arnott CH, Scott KA, Moore RJ, Robinson SC, Thompson RG, Balkwill FR.
    Oncogene; 2004 Mar 11; 23(10):1902-10. PubMed ID: 14661063
    [Abstract] [Full Text] [Related]

  • 14. Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice.
    Song HY, Lee JA, Ju SM, Yoo KY, Won MH, Kwon HJ, Eum WS, Jang SH, Choi SY, Park J.
    Biochem Pharmacol; 2008 Mar 15; 75(6):1348-57. PubMed ID: 18164693
    [Abstract] [Full Text] [Related]

  • 15. Regulation of two forms of the TNF receptors by phorbol ester and dibutyryl cyclic adenosine 3',5'-monophosphate in human histiocytic lymphoma cell line U-937.
    Aggarwal BB, Graff K, Samal B, Higuchi M, Liao WS.
    Lymphokine Cytokine Res; 1993 Jun 15; 12(3):149-58. PubMed ID: 7688579
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment.
    Aldaz CM, Conti CJ, Gimenez IB, Slaga TJ, Klein-Szanto AJ.
    Cancer Res; 1985 Jun 15; 45(6):2753-9. PubMed ID: 3986807
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis.
    Yasukawa K, Iida T, Fujimoto Y.
    J Pharm Pharmacol; 2009 Aug 15; 61(8):1051-6. PubMed ID: 19703349
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity.
    Honda T, Matsuoka T, Ueta M, Kabashima K, Miyachi Y, Narumiya S.
    J Allergy Clin Immunol; 2009 Oct 15; 124(4):809-18.e2. PubMed ID: 19541354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.